Congressional trades by ticker
BMY congressional trades
- Verified rows
- 16
- Filers
- 8
- Purchases
- 6
- Latest trade
- 2026-05-07
Verified BMY House disclosures
Parsed from official House Clerk periodic transaction reports. This snapshot contains 6 purchases and 10 sales. Reported owners: Spouse, Self, Joint. Transaction dates run from 2024-10-23 to 2026-05-07.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Mike Kelly | Bristol-Myers Squibb Company Common Stock | Sale | Spouse | $15,001 - $50,000 | #20034767 Filed 2026-06-11 | |
| Gilbert Cisneros | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20033762 Filed 2026-01-12 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20033789 Filed 2026-01-15 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20033611 Filed 2025-12-11 | |
| Gilbert Cisneros | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20033619 Filed 2025-12-15 | |
| Gilbert Cisneros | Bristol-Myers Squibb Company Common Stock | Sale | Self | $1,001 - $15,000 | #20033455 Filed 2025-11-18 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20032066 Filed 2025-09-11 | |
| Virginia Foxx | Bristol-Myers Squibb Company Common Stock | Sale | Self | $1,001 - $15,000 | #20030587 Filed 2025-07-03 | |
| Jefferson Shreve | Bristol-Myers Squibb Company Common Stock | Sale | Self | $15,001 - $50,000 | #20030387 Filed 2025-06-22 | |
| Julia Letlow | Bristol-Myers Squibb Company Common Stock | Sale | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20030296 Filed 2025-05-14 | |
| Greg Landsman | Bristol-Myers Squibb Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20029084 Filed 2025-04-08 | |
| Julie Johnson | Bristol-Myers Squibb Company Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026762 Filed 2025-02-12 | |
| Virginia Foxx | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20026516 Filed 2025-01-06 | |
| Valerie Hoyle | Bristol-Myers Squibb Company Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 | |
| Julia Letlow | Bristol-Myers Squibb Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
The filing is free
Keep the BMY range and owner as filed. Membership adds the investment view around the money, not a list to copy.
Related research
BMY congressional trades — FAQ
Who in Congress traded BMY?
House Clerk periodic reports for 2025 and 2026 contain 16 verified BMY rows from 8 members: Gilbert Cisneros, Greg Landsman, Jefferson Shreve, Julia Letlow, and 4 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current BMY holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are BMY amounts shown as ranges?
House periodic transaction reports use statutory value bands such as $15,001 - $50,000; $1,001 - $15,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is BMY congressional-trade coverage?
This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded BMY.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported BMY and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included